Lansoprazole, Clarithromycin and Amoxicillin |
Prevpac |
Clinical Trial: The Safety and Effectiveness of Clarithromycin and Rifabutin Used Alone or in Combination to Prevent Mycobacterium Avium Complex (MAC) or Disseminated MAC Disease in HIV-Infected Patients
This study has been completed.
|
Purpose
To compare the efficacy and safety of clarithromycin alone versus rifabutin alone versus the two drugs in combination for the prevention or delay of Mycobacterium avium Complex (MAC) bacteremia or disseminated MAC disease. To compare other parameters such as survival, toxicity, and quality of life among the three treatment arms. To obtain information on the incidence and clinical grade of targeted gynecologic conditions. Persons with advanced stages of HIV are considered to be at particular risk for developing disseminated MAC disease. The development of an effective regimen for the prevention of disseminated MAC disease may be of substantial benefit in altering the morbidity and possibly the mortality associated with this disease and its treatment.
| Condition | Treatment or Intervention | Phase |
|---|---|---|
| Mycobacterium avium-intracellulare Infection HIV Infections | Drug: Clarithromycin Drug: Rifabutin | Phase III |
MedlinePlus related topics: AIDS; Bacterial Infections
Study Type: Interventional
Study Design: Treatment
Official Title: A Prospective, Randomized, Comparative Study of the Safety and Efficacy of Clarithromycin Versus Rifabutin Versus the Combination of Clarithromycin Plus Rifabutin for the Prevention of Mycobacterium avium Complex (MAC) Bacteremia or Disseminated MAC Disease in HIV-Infected Patients with CD4 Lymphocyte Counts <= 100 Cells/mm3
Expected Total Enrollment: 1100
Persons with advanced stages of HIV are considered to be at particular risk for developing disseminated MAC disease. The development of an effective regimen for the prevention of disseminated MAC disease may be of substantial benefit in altering the morbidity and possibly the mortality associated with this disease and its treatment.
Patients are randomized to receive clarithromycin alone, rifabutin alone, or the two drugs in combination daily. Patients are evaluated every 4 weeks for the first 8 weeks and every 8 weeks thereafter for the duration of the study. Patients are followed for 24 months. Per amendment, a pharmacokinetic substudy will be conducted.
Eligibility
Ages Eligible for Study: 12 Years and above, Genders Eligible for Study: Both
Criteria
Inclusion Criteria
Concurrent Medication: Recommended:
- PCP prophylaxis.
Allowed:
- GM-CSF or G-CSF.
- Erythropoietin.
- Therapies (including antiretrovirals) available through expanded access or treatment IND programs.
- Other non-experimental therapies available by prescription.
- Antihistamines other than those specifically excluded.
Patients must have:
- Evidence or diagnosis of HIV infection or a history of an AIDS-defining condition by CDC criteria.
- CD4 count <= 100 cells/mm3 within 90 days prior to study entry.
- Two baseline blood sample cultures negative for MAC within 30 days of study entry.
- No suspected disseminated MAC disease, in the opinion of the clinician.
NOTE:
- Patients with elevated GGT and/or triglycerides are allowed.
NOTE:
- Patients may co-enroll on ACTG 081/981/181, ACTG 175, ACTG 204, ACTG 193, ACTG 241, or other acceptable protocols.
Exclusion Criteria
Co-existing Condition: Patients with the following symptoms or conditions are excluded:
- Known or suspected tuberculous infection or other non-tuberculous mycobacterial infection requiring chemotherapy or chemoprophylaxis (with the exception of isoniazid prophylaxis alone).
NOTE:
- Patients may enroll who successfully completed tuberculosis (TB) treatment and have been off anti-TB drugs for more than 6 months with no symptoms of mycobacterial infection.
- Active TB.
- Known hypersensitivity to study drugs.
- Malabsorption as defined by persistent diarrhea with more than 8 stools per day for > 6 weeks.
Concurrent Medication: Excluded:
- Frequent (more than once per month), repeated, or continuous treatment courses of quinolones, erythromycin, spiramycin, azithromycin, clarithromycin, or clindamycin.
- Concomitant terfenadine or astemizole.
Prior Medication: Excluded:
- Prophylaxis with azithromycin, clarithromycin, or rifabutin for more than 4 months.
Location Information
Alabama
Univ of Alabama at Birmingham, Birmingham, Alabama, 35294, United States
California
Sepulveda Veterans Adm Med Ctr / Olive View Med Ctr, Sylmar, California, 91342, United States
San Francisco Gen Hosp, San Francisco, California, 941102859, United States
San Francisco AIDS Clinic / San Francisco Gen Hosp, San Francisco, California, 941102859, United States
Summitt Med Ctr / San Francisco Gen Hosp, Oakland, California, 94609, United States
UCLA CARE Ctr, Los Angeles, California, 90095, United States
Children's Hosp of Los Angeles, Los Angeles, California, 90027, United States
Community Consortium of San Francisco, San Francisco, California, 94110, United States
Highland Gen Hosp / San Francisco Gen Hosp, Oakland, California, 946021018, United States
Olive View Med Ctr, Sylmar, California, 91342, United States
Colorado
Mountain States Reg Hemo Ctr / Univ of Colorado, Denver, Colorado, 80262, United States
Denver CPCRA / Denver Public Hlth, Denver, Colorado, 802044507, United States
Children's Hosp of Denver, Denver, Colorado, 802181088, United States
Connecticut
Yale Univ / New Haven, New Haven, Connecticut, 065102483, United States
Delaware
Wilmington Hosp / Med Ctr of Delaware, Wilmington, Delaware, 19899, United States
District of Columbia
Veterans Administration Med Ctr / Regional AIDS Program, Washington, District of Columbia, 20422, United States
Howard Univ, Washington, District of Columbia, 20059, United States
Georgetown Univ Med Ctr, Washington, District of Columbia, 20007, United States
Whitman - Walker Clinic / Georgetown Univ Med Ctr, Washington, District of Columbia, 200072197, United States
HIV Ctr - District of Columbia Gen Hosp, Washington, District of Columbia, 200072197, United States
Florida
Univ of Miami School of Medicine, Miami, Florida, 331361013, United States
Georgia
AIDS Research Consortium of Atlanta, Atlanta, Georgia, 30308, United States
Hawaii
Univ of Hawaii, Honolulu, Hawaii, 96816, United States
Illinois
Children's Mem Hosp Family Cln / Northwestern Univ Med Schl, Chicago, Illinois, 60611, United States
Lakeside Veterans Adm / Northwestern Univ Med School, Chicago, Illinois, 60611, United States
Chicago Children's Memorial Hosp, Chicago, Illinois, 606143394, United States
Northwestern Univ Med School, Chicago, Illinois, 60611, United States
Rush Presbyterian - Saint Luke's Med Ctr, Chicago, Illinois, 60612, United States
AIDS Research Alliance - Chicago, Chicago, Illinois, 60657, United States
Cook County Hosp, Chicago, Illinois, 60612, United States
Indiana
Indiana Univ Hosp, Indianapolis, Indiana, 462025250, United States
Methodist Hosp of Indiana / Life Care Clinic, Indianapolis, Indiana, 46202, United States
Iowa
Univ of Iowa Hosp and Clinic, Iowa City, Iowa, 52242, United States
Louisiana
Louisiana Comm AIDS Rsch Prog / Tulane Univ Med, New Orleans, Louisiana, 70112, United States
Maryland
Johns Hopkins Hosp, Baltimore, Maryland, 21287, United States
State of MD Div of Corrections / Johns Hopkins Univ Hosp, Baltimore, Maryland, 212052196, United States
Massachusetts
Harvard (Massachusetts Gen Hosp), Boston, Massachusetts, 02114, United States
Beth Israel Deaconess Med Ctr, Boston, Massachusetts, 02215, United States
Beth Israel Deaconess - West Campus, Boston, Massachusetts, 02215, United States
Boston Med Ctr, Boston, Massachusetts, 02118, United States
Michigan
Henry Ford Hosp, Detroit, Michigan, 48202, United States
Minnesota
Univ of Minnesota, Minneapolis, Minnesota, 55455, United States
St Paul Ramsey Med Ctr, St. Paul, Minnesota, 55101, United States
Hennepin County Med Clinic, Minneapolis, Minnesota, 55415, United States
Missouri
St Louis Regional Hosp / St Louis Regional Med Ctr, St. Louis, Missouri, 63112, United States
Nebraska
Univ of Nebraska Med Ctr, Omaha, Nebraska, 681985130, United States
New Jersey
North Jersey Community Research Initiative, Newark, New Jersey, 071032842, United States
New York
Montefiore Drug Treatment Ctr / Bronx Municipal Hosp, Bronx, New York, 10461, United States
Montefiore Family Health Ctr / Bronx Municipal Hosp, Bronx, New York, 10461, United States
Samaritan Village Inc / Bronx Municipal Hosp, Bronx, New York, 10461, United States
SUNY / State Univ of New York, Syracuse, New York, 13210, United States
Univ of Rochester Medical Center, Rochester, New York, 14642, United States
Mem Sloan - Kettering Cancer Ctr, New York, New York, 10021, United States
Bellevue Hosp / New York Univ Med Ctr, New York, New York, 10016, United States
Mount Sinai Med Ctr, New York, New York, 10029, United States
Jack Weiler Hosp / Bronx Municipal Hosp, Bronx, New York, 10465, United States
Cornell Univ Med Ctr, New York, New York, 10021, United States
Bronx Municipal Hosp Ctr/Jacobi Med Ctr, Bronx, New York, 10461, United States
Montefiore Med Ctr / Bronx Municipal Hosp, Bronx, New York, 10467, United States
SUNY / Erie County Med Ctr at Buffalo, Buffalo, New York, 14215, United States
Bronx Lebanon Hosp Ctr, Bronx, New York, 10457, United States
Mount Sinai Med Ctr / Hemophilia Treatment Ctr, New York, New York, 10029, United States
Clinical Directors Network of Region II, New York, New York, 10011, United States
Beth Israel Med Ctr, New York, New York, 10003, United States
City Hosp Ctr at Elmhurst / Mount Sinai Hosp, Elmhurst, New York, 11373, United States
Montefiore Med Ctr Adolescent AIDS Program, Bronx, New York, 10467, United States
SUNY / Health Sciences Ctr at Brooklyn, Brooklyn, New York, 112032098, United States
Saint Clare's Hosp and Health Ctr, New York, New York, 10019, United States
North Shore Univ Hosp, Manhasset, New York, 11030, United States
North Central Bronx Hosp / Bronx Municipal Hosp, Bronx, New York, 10467, United States
Comprehensive Health Care Ctr / Bronx Municipal Hosp, Bronx, New York, 10461, United States
Columbia Presbyterian Med Ctr, New York, New York, 100323784, United States
Adirondack Med Ctr at Saranac Lake, Albany, New York, 122083479, United States
Mid - Hudson Care Ctr, Albany, New York, 122083479, United States
Albany Med College / Division of HIV Medicine A158, Albany, New York, 122083479, United States
North Carolina
Carolinas Med Ctr, Charlotte, North Carolina, 28203, United States
Univ of North Carolina, Chapel Hill, North Carolina, 275997215, United States
Moses H Cone Memorial Hosp, Greensboro, North Carolina, 27401, United States
Glaxo Wellcome Inc, Research Triangle Park, North Carolina, 27709, United States
Ohio
Case Western Reserve Univ, Cleveland, Ohio, 44106, United States
Univ of Cincinnati, Cincinnati, Ohio, 452670405, United States
Ohio State Univ Hosp Clinic, Columbus, Ohio, 432101228, United States
Med College of Ohio, Toledo, Ohio, 43699, United States
MetroHealth Med Ctr, Cleveland, Ohio, 441091998, United States
Oregon
Portland Veterans Adm Med Ctr / Rsch & Education Grp, Portland, Oregon, 972109951, United States
Pennsylvania
Univ of Pennsylvania at Philadelphia, Philadelphia, Pennsylvania, 19104, United States
Children's Hosp of Philadelphia, Philadelphia, Pennsylvania, 191044318, United States
Thomas Jefferson Univ Hosp, Philadelphia, Pennsylvania, 191075098, United States
South Carolina
Julio Arroyo, West Columbia, South Carolina, 29169, United States
Texas
Univ Texas Health Science Ctr / Univ Texas Med School, Houston, Texas, 77030, United States
Univ of Texas Galveston, Galveston, Texas, 775550435, United States
Virginia
Richmond AIDS Consortium, Richmond, Virginia, 23298, United States
Washington
Univ of Washington, Seattle, Washington, 981224304, United States
Benson CA, Study Chair
Cohn DL, Study Chair
More Information
Click here for more information about Rifabutin
Click here for more information about Clarithromycin
Publications
Currier JS, Williams P, Feinberg J, Becker S, Owens S, Benson CA. ACTG 815: a prospective study of bacterial infections in advanced HIV disease. Conf Retroviruses Opportunistic Infect. 1997 Jan 22-26;4th:131 (abstract no 364)
Mascolini M. FDA advisory committee deadlocks on delavirdine. Food and Drug Administration. AIDS Treat News. 1996 Dec 6;(No 260):3-5. No abstract available.
Watts DH, Spino C, Benson C, Yu B, Katzenstein D, Hammer S, Stratton P, Korvick J. A comparison of gynecologic findings in HIV-positive women with CD4 lymphocyte counts 200 to 500/cc and less than 100/cc. Int Conf AIDS. 1996 Jul 7-12;11(2):275 (abstract no ThB4137)
Fichtenbaum CJ, Zackin R, Feinberg J, Benson C, Griffiths JK. Rifabutin but not clarithromycin prevents cryptosporidiosis in persons with advanced HIV infection. AIDS. 2000 Dec 22;14(18):2889-93.
Cohn DL. Prevention strategies for Mycobacterium avium-intracellulare complex (MAC) infection. A review of recent studies in patients with AIDS. Drugs. 1997;54 Suppl 2:8-15; discussion 28-9. Review.
Watts DH, Spino C, Zaborski L, Katzenstein D, Hammer S, Benson C. Comparison of gynecologic history and laboratory results in HIV-positive women with CD4+ lymphocyte counts between 200 and 500 cells/microl and below 100 cells/microl. J Acquir Immune Defic Syndr Hum Retrovirol. 1999 Apr 15;20(5):455-62.
Fichtenbaum CJ, Powderly WG. Refractory mucosal candidiasis in patients with human immunodeficiency virus infection. Clin Infect Dis. 1998 Mar;26(3):556-65. Review.
Benson CA, Williams PL, Cohn DL, Becker S, Hojczyk P, Nevin T, Korvick JA, Heifets L, Child CC, Lederman MM, Reichman RC, Powderly WG, Notario GF, Wynne BA, Hafner R. Clarithromycin or rifabutin alone or in combination for primary prophylaxis of Mycobacterium avium complex disease in patients with AIDS: A randomized, double-blind, placebo-controlled trial. The AIDS Clinical Trials Group 196/Terry Beirn Community Programs for Clinical Research on AIDS 009 Protocol Team. J Infect Dis. 2000 Apr;181(4):1289-97.
Currier JS, Williams P, Feinberg J, Becker S, Owens S, Fichtenbaum C, Benson C. Impact of prophylaxis for Mycobacterium avium complex on bacterial infections in patients with advanced human immunodeficiency virus disease. Clin Infect Dis. 2001 Jun 1;32(11):1615-22.
Record last reviewed: January 2003
Last Updated: April 7, 2005
Record first received: November 2, 1999
ClinicalTrials.gov Identifier: NCT00001030
Health Authority: United States: Federal Government
ClinicalTrials.gov processed this record on 2005-04-08
Source: ClinicalTrials.gov
Cache Date: April 9, 2005
Resources
- Lansoprazole, Clarithromycin and Amoxicillin (Drug Digest)
- Prevpac (Drug Digest)

Not Signed In -

